Phase II NAUTIKA1 study of targeted therapies in stage II-III NSCLC: Preliminary data of neoadjuvant alectinib for ALK+ NSCLC Meeting Abstract
| Authors: | Lee, J. M.; Sepesi, B.; Toloza, E. M.; Pass, H. I.; Lin, J.; Johnson, B. E.; Heymach, J. V.; Johnson, M. L.; Ding, B.; Schulze, K.; Zhu, Q.; Ngiam, C.; Brandàƒo, E.; Bara, I.; Chaft, J. |
| Abstract Title: | Phase II NAUTIKA1 study of targeted therapies in stage II-III NSCLC: Preliminary data of neoadjuvant alectinib for ALK+ NSCLC |
| Meeting Title: | 2022 World Conference on Lung Cancer |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 17 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2022 Aug 6-9 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-09-01 |
| Start Page: | S233 |
| End Page: | S234 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2022.07.390 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: EP02.04-005 -- Located within section named "EP02.04 Early Stage Non-Small Cell Lung Cancer - Systemic Therapy" -- Accession Number: 159037636 -- Entry Date: In Process -- Revision Date: 20220913 -- Publication Type: Article -- Supplement Title: 2022 Supplement -- Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101274235. -- Source: Cinahl |
